Oncology

Brain Tumors: Trials and Treatment

Dr. Yaron Moshel is co-director of The Brain Tumor Center of New Jersey at Atlantic Health System’s Overlook Medical Center in Summit and part of the neurosurgical team at Atlantic Neurosurgical Specialists in Morristown. He is also Clinical Assistant Professor of Neurosurgery at NYU Langone Medical Center.

Dr. Moshel is one of a select few surgeons who specialize in removing deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. Dr. Moshel is a vital part of Overlook Medical Center’s CyberKnife Program making it the largest CyberKnife Program in the tri-state region for the treatment of brain tumors. Dr. Moshel is also actively involved in advancing the treatment of brain tumors and actively participates in national multicenter clinical trials, most recently working with an autologous dendritic cell vaccine and on a retroviral vaccine trial for recurrent brain tumors.

Previously Assistant Professor of Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Dr. Moshel’s clinical interests and neurosurgical abilities extend beyond the treatment of brain tumors. He is experienced in the surgical approaches for skull base and spine tumors and in endoscopic transnasal surgery for pituitary and skull base lesions. His practice also encompasses the surgical treatment of epilepsy and minimally invasive treatment of trigeminal neuralgia.

Breast Cancer

Dr. Azu is a graduate of the University of Missouri School of Medicine, in Columbia, MO. She completed her MSKCC breast fellowship in 2009. Her research interests are the influence of psychosocial and epidemiological factors on outcomes in breast cancer patients, and the effect of media on patient care. She is steadfast in her commitment to ensure patients understand their diagnosis, and has received numerous patient care accolades. She currently serves as a member of the American Cancer Society’s editorial board as well as multiple other leadership roles.

More about Brain Tumors

Dr. Yaron Moshel is co-director of The Brain Tumor Center of New Jersey at Atlantic Health System’s Overlook Medical Center in Summit and part of the neurosurgical team at Atlantic Neurosurgical Specialists in Morristown. He is also Clinical Assistant Professor of Neurosurgery at NYU Langone Medical Center.

Dr. Moshel is one of a select few surgeons who specialize in removing deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. Dr. Moshel is a vital part of Overlook Medical Center’s CyberKnife Program making it the largest CyberKnife Program in the tri-state region for the treatment of brain tumors. Dr. Moshel is also actively involved in advancing the treatment of brain tumors and actively participates in national multicenter clinical trials, most recently working with an autologous dendritic cell vaccine and on a retroviral vaccine trial for recurrent brain tumors.

Previously Assistant Professor of Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Dr. Moshel’s clinical interests and neurosurgical abilities extend beyond the treatment of brain tumors. He is experienced in the surgical approaches for skull base and spine tumors and in endoscopic transnasal surgery for pituitary and skull base lesions. His practice also encompasses the surgical treatment of epilepsy and minimally invasive treatment of trigeminal neuralgia.

Head & Neck Cancer

Dr. Erik Cohen is an ENT-otolaryngologist in Morristown, New Jersey and is affiliated with Morristown Medical Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice for more than 20 years.

Brain Tumors

Dr. Yaron Moshel is co-director of The Brain Tumor Center of New Jersey at Atlantic Health System’s Overlook Medical Center in Summit and part of the neurosurgical team at Atlantic Neurosurgical Specialists in Morristown. He is also Clinical Assistant Professor of Neurosurgery at NYU Langone Medical Center.

Dr. Moshel is one of a select few surgeons who specialize in removing deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. Dr. Moshel is a vital part of Overlook Medical Center’s CyberKnife Program making it the largest CyberKnife Program in the tri-state region for the treatment of brain tumors. Dr. Moshel is also actively involved in advancing the treatment of brain tumors and actively participates in national multicenter clinical trials, most recently working with an autologous dendritic cell vaccine and on a retroviral vaccine trial for recurrent brain tumors.

Previously Assistant Professor of Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Dr. Moshel’s clinical interests and neurosurgical abilities extend beyond the treatment of brain tumors. He is experienced in the surgical approaches for skull base and spine tumors and in endoscopic transnasal surgery for pituitary and skull base lesions. His practice also encompasses the surgical treatment of epilepsy and minimally invasive treatment of trigeminal neuralgia.

Pancreatic Cancer

Dr. Aaron Chevinsky is a surgeon in Milwaukee, Wisconsin and is affiliated with Aurora St. Luke’s Medical Center. He received his medical degree from Stony Brook University School of Medicine and has been in practice for more than 20 years.

Breast Cancer

“One of the first Fellowship-trained breast surgeons in the United States, Dr. Elliott started her Montclair practice in 1989. She completed training in breast disease at UMDNJ/Robert Wood Johnson University Hospital. She received her medical degree from Mount Sinai Medical Center and completed a general surgery residency at St. Vincent’s Hospital, in New York City. Dr. Elliott graduated with honors from Barnard College, Columbia University. Dr. Elliott is well known not only for medical expertise in the field of breast disease evaluation and treatment, but particularly for her sensitivity and commitment to her patients. She has been honored by the New Jersey General Assembly and Montclair Economic Development Council as “Outstanding Woman of the Year in Science,” for her distinction as the founder and director of the Montclair Breast Center and as a “superlative physician who exemplifies the spirit of caring and compassion.” Dr. Elliott lectures extensively on breast cancer to professional and public groups and has had numerous appearances on national TV as a breast cancer specialist. She is a member of many professional societies including the President’s Council of the National Breast Cancer Coalition and a member of the New York Metropolitan Breast Cancer Group.She received the “Luster for Life” Award at the 32nd Annual American Cancer Society’s Diamond Ball and was voted “Top Doc” by her peers in NJ Monthly magazine. She was also named a “Top Doc” in the September, 2014 Montclair Magazine.”

Dr. LaSalle assisted with the successful clinical and educational launches of Pfizer’s blockbuster drug Viagra™ as well as GlaxoSmithKline / Bayer Corporation’s Levitra™ and Eli Lilly / Icos Corporation’s Cialis™ in collaboration with the internationally renowned Dr. Irwin Goldstein at the Boston University School of Medicine, Boston, Massachusetts. Utilizing pre and post operative penile rehabilitation protocols with these medications, various injectable erectogenic agents and the unique non-cautery athermal nerve sparing robotic surgical technique developed by Dr. Michael Esposito, the patients undergoing laparoscopic robotic assisted surgery for prostate cancer have a very high recovery rate of preoperative sexual function.

Cervical Cancer

Dr. Craig L. Bissinger is an obstetrician-gynecologist in Parsippany, New Jersey and is affiliated with Morristown Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice for more than 20 years.

Radiation Oncology

Alison Grann, MD, Chairwoman, board-certified Radiation Oncologist, joined the Depar tment of Radiation Oncology at Saint Barnabas Medical Center in Februar y 2000. Previously, Dr. Grann practiced at Memorial Sloan- Kettering Cancer Center in Manhattan where she worked in the Depar tment of Radiation Oncology.

Dr. Grann graduated cum laude from George Washington University in Washington, DC, followed by her medical degree at the George Washington University School of Medicine. She completed residencies in internal medicine at Harvard Medical School, Beth Israel Hospital in Boston, MA, and in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York, NY where she served as Chief Resident. Dr. Grann is committed to research and is a thought-leader in the field of radiation oncology and has served as principal investigator on several different clinical trials. She has completed over 20 research projects, publications, conference proceedings, abstracts, and book chapters. In addition, she is a member of numerous medical organizations including; American Society for Therapeutic Radiology Oncology, American Society of Clinical Oncology, American Medical Association, Metropolitan Breast Group and Society of Breast Diseases.

Dr. Grann takes a special interest in the treatment and research of breast cancer, brain tumors, prostate cancer, gastrointestinal cancers. She has extensive expertise in various treatment options; including stereotactic radiosurgery (SRS), three-dimensional conformal radiation therapy (3D-CRT), intensity modulated radiation therapy (IMRT), stereotactic radiosurger y (SRS), stereotactic body radiation therapy (SBRT), and low-dose rate (LDR) brachytherapy, proton therapy, intraoperative radiation therapy, hyper thermia.

Dr. Grann has received numerous awards and honors and is consistently listed in “Top Doctors” in NJ Monthly Magazine and “Best Doctors in America” Castle Connelly. In addition, Dr. Grann serves on the Board of Trustees for Saint Barnabas Medical Center and is committed to service in the community.

Ovarian Cancer

Dr. Brian Slomovitz is the Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Miami Miller School of Medicine. He is also the Co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center and Fellowship Director for the Division. Prior to joining Sylvester, Dr. Slomovitz was an Associate Professor at the Icahn School of Medicine at Mount Sinai of Medicine and Adjunct Associate Professor at MD Anderson Cancer Center. He was also the Director of Cancer Research at Atlantic Health Systems in Northern New Jersey.

Dr. Slomovitz has a keen interest in applying the principles learned from the lab to the clinical setting. He is a principal investigator in a number of Gynecologic Oncology Group (GOG) clinical trials focusing on endometrial and vulvar cancer. He has authored or co-authored more than 60 peer-reviewed articles and has lectured extensively.

Dr. Slomovitz received a Master’s degree from Georgetown University in 1993, graduated from medical school at the Rutgers University – New Jersey Medical School in 1998, and completed his residency at New York Presbyterian – Cornell Medical Center in 2002. At the University of Texas MD Anderson Cancer Center, he completed a fellowship in gynecologic oncology in 2006. He is board certified in both obstetrics and gynecology and gynecologic oncology.